Interview with Kevin Winter (Global CISO at Deloitte) and Richard Marcus (CISO at AuditBoard) who are top CISOs at major ...
Full Year 2024 Results Key Financial Results Revenue: US$3.87b (down 2.2% from FY 2023).
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback